Valuation: Biogen Inc.

Market Cap 3.04TCr 2.66TCr 2.46TCr 2.27TCr 4.31TCr 2,90800Cr 4.39TCr 30TCr 11TCr 1,42300Cr 11TCr 11TCr 4,94000Cr P/E 2026 *
31.3x
P/E 2027 * 17.2x
Enterprise Value 3.59TCr 3.15TCr 2.91TCr 2.68TCr 5.09TCr 3,43500Cr 5.19TCr 35TCr 14TCr 1,68100Cr 13TCr 13TCr 5,83600Cr EV / Sales 2026 *
3.57x
EV / Sales 2027 * 3.25x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day-1.18%
1 week-3.87%
Current month-6.68%
1 month+4.67%
3 months+12.07%
6 months+8.40%
Current year+14.56%
1 week 198.93
Extreme 198.93
219.02
1 month 193.2
Extreme 193.195
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 121.05
Extreme 121.05
219.72
3 years 110.04
Extreme 110.035
282.74
5 years 110.04
Extreme 110.035
372.12
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06Free

Director

1,505 0.0010%
09/06Free

Director

1,505 0.0010%
09/06Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.18%-3.87%+49.95%-28.40% 3.04TCr
-1.87%+5.97%+20.86%-5.88% 6.88TCr
-2.01%-3.57%+46.21%+217.06% 5.52TCr
-4.15%+36.30%+36.30%+36.30% 4.35TCr
+0.27%+8.33%-49.87%-53.43% 4.12TCr
-7.00%+3.14%+129.79%-39.25% 3.17TCr
-1.20%+2.42%+72.25%+88.33% 2.36TCr
-1.15%+8.29%+4.42%+184.96% 1.93TCr
-1.33%+1.11%+66.11%+131.83% 1.72TCr
-0.64%+3.72%+78.95%+345.22% 1.53TCr
Average -2.01%+3.83%+45.50%+87.67% 3.46TCr
Weighted average by Cap. -2.14%+3.59%+38.34%+63.71%

Financials

2026 *2027 *
Net sales 1.01TCr 881.52Cr 813.84Cr 752.06Cr 1.43TCr 96TCr 1.45TCr 9.78TCr 3.8TCr 47TCr 3.77TCr 3.69TCr 1,63500Cr 1.04TCr 910.89Cr 840.96Cr 777.12Cr 1.47TCr 99TCr 1.5TCr 10TCr 3.93TCr 49TCr 3.9TCr 3.81TCr 1,68900Cr
Net income 152.22Cr 133.51Cr 123.26Cr 113.91Cr 215.9Cr 15TCr 220.22Cr 1.48TCr 575.76Cr 7.13TCr 571.63Cr 559.11Cr 25TCr 196.89Cr 172.69Cr 159.43Cr 147.33Cr 279.25Cr 19TCr 284.84Cr 1.92TCr 744.71Cr 9.23TCr 739.37Cr 723.17Cr 32TCr
Net Debt 550.87Cr 483.17Cr 446.08Cr 412.21Cr 781.31Cr 53TCr 796.95Cr 5.36TCr 2.08TCr 26TCr 2.07TCr 2.02TCr 90TCr 338.49Cr 296.89Cr 274.1Cr 253.29Cr 480.08Cr 32TCr 489.69Cr 3.3TCr 1.28TCr 16TCr 1.27TCr 1.24TCr 55TCr
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
08/26/08 $201.80 -1.90% 8,23,791
07/26/07 $205.70 -1.32% 11,56,880
06/26/06 $208.46 -3.54% 12,18,492
02/26/02 $216.12 +3.04% 11,55,165
01/26/01 $209.74 -2.93% 11,38,639
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
205.70USD
Average target price
222.38USD
Spread / Average Target
+8.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock